돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2171639생성일: 2026년 10월 25일

tert-Butyl piperazine-1-carboxylate → 4-[5-(Piperazin-1-yl)pyrimidin-2-yl]morpholine

https://huagongshe.com/reaction/2171639

반응식

참여 물질

역할이름HCID투입량
반응물tert-Butyl piperazine-1-carboxylateHCID 143452—
반응물Binap, (A+-)-HCID 634876—
반응물4-(5-Bromopyrimidin-2-yl)morpholineHCID 5144362—
반응물1,4-Dioxane hydrochlorideHCID 20443148—
반응물Potassium tert-butoxideHCID 23665647—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매EthanolHCID 702—
용매TolueneHCID 1140—
생성물4-[5-(Piperazin-1-yl)pyrimidin-2-yl]morpholineHCID 8668621133.4%

반응 조건

온도90 °C

반응 단계

Under argon atmosphere, 4-(5-bromopyrimidin-2-yl)morpholine (700 mg) and tert-butyl piperazine-1-carboxylate (800 mg) were mixed with toluene (10 ml), and Pd2(dba)3 (130 mg), BINAP (260 mg), and potassium tert-butoxide (500 mg) were added thereto, followed by stirring at 90° C. overnight. The reaction mixture was cooled to room temperature, the reaction mixture was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (hexane/EtOAc). The purified product thus obtained was mixed with EtOH (10 ml), and 4M hydrogen chloride/dioxane (7 ml) was added thereto, followed by stirring at room temperature overnight. The reaction mixture was concentrated under reduced pressure, and CHCl3 and a saturated aqueous sodium hydrogen carbonate solution were then added thereto. The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (CHCl3/MeOH) to obtain 4-[5-(piperazin-1-yl)pyrimidin-2-yl]morpholine (239 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09051283B2
출처 데이터셋uspto-grants-2015_06
ORD IDord-8053b697682e424db7ada80532af83cf
출처 메모uspto-grants-2015_06